Celon Pharma S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was PLN 40.33 million compared to PLN 43.89 million a year ago. Net loss was PLN 15.67 million compared to PLN 9.48 million a year ago.

Basic loss per share from continuing operations was PLN 0.31 compared to PLN 0.19 a year ago. Diluted loss per share from continuing operations was PLN 0.31 compared to PLN 0.19 a year ago.